(Q38044503)

27 August 2017

IST-3: a major contribution to thrombolysis research (English)

1 reference

27 August 2017

1 reference

1

Geoffrey A Donnan

1 reference

27 August 2017

Stephen M Davis

2

1 reference

27 August 2017

1 October 2012

1 reference

International Journal of Stroke

27 August 2017

1 reference

27 August 2017

7

1 reference

27 August 2017

7

1 reference

27 August 2017

566-567

1 reference

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

27 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00938.X

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00938.X

A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00938.X

A randomized trial of tenecteplase versus alteplase for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00938.X

Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00938.X

10.1111/J.1747-4949.2012.00938.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22989392